Title: Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients
with advanced hepatocellular carcinoma from Japanese real-world practice
Version: 6 Date: 06 Mar 2023
Reviewer's report:
All comments have been adequately addressed.
Title: Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients
with advanced hepatocellular carcinoma from Japanese real-world practice
Version: 6 Date: 06 Mar 2023
Reviewer's report:
All comments have been adequately addressed.
Please review this paper.
user
Title: Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients
with advanced hepatocellular carcinoma from Japanese real-world practice
Version: 6 Date: 06 Mar 2023
Reviewer's report:
All comments have been adequately addressed.
assistant